In this article we review the glucagon like peptide -1 receptor agonist (GLP-1) medications and discuss how to approach using them for weight loss and management in non-diabetic patients.
View Article and Find Full Text PDFAmyotrophic lateral sclerosis (ALS) is characterised primarily by motor system degeneration, with clinical evidence of cognitive and behavioural change in up to 50% of cases. We have shown previously that resting-state EEG captures dysfunction in motor and cognitive networks in ALS. However, the longitudinal development of these dysfunctional patterns, especially in networks linked with cognitive-behavioural functions, remains unclear.
View Article and Find Full Text PDF